咨询与建议

限定检索结果

文献类型

  • 1 篇 期刊文献

馆藏范围

  • 1 篇 电子文献
  • 0 种 纸本馆藏

日期分布

学科分类号

  • 1 篇 医学
    • 1 篇 临床医学

主题

  • 1 篇 ovarian cancer
  • 1 篇 platinum resista...
  • 1 篇 parpi resistance
  • 1 篇 ddr

机构

  • 1 篇 obstetrics gynec...
  • 1 篇 department of me...
  • 1 篇 division of gyne...
  • 1 篇 center for cance...
  • 1 篇 division of hema...
  • 1 篇 department of ob...

作者

  • 1 篇 liron bar-peled
  • 1 篇 yusuke matoba
  • 1 篇 lauren philp
  • 1 篇 varvara mazina
  • 1 篇 sara bouberhan
  • 1 篇 bo r.eda

语言

  • 1 篇 英文
检索条件"作者=Liron Ba.-peled"
1 条 记 录,以下是1-10 订阅
排序:
The evolving role of DNA damage response in overcoming therapeutic resistance in ovarian cancer
收藏 引用
Cancer Drug Resistance 2023年 第2期6卷 345-357页
作者: Sara Bouberhan liron ba.-peled Yusuke Matoba.Varvara Mazina Lauren Philp Bo R.eda Division of Hematology/Oncology Department of MedicineMassachusetts General HospitalBostonMA 02114USA Department of Medicine Harvard Medical SchoolBostonMA 02115USA Center for Cancer Research Massachusetts General HospitalBostonMA 02114USA Department of Obstetrics and Gynecology Vincent Center for Reproductive BiologyMassachusetts General HospitalBostonMA 02114USA Obstetrics Gynecologyand Reproductive BiologyHarvard Medical SchoolBostonMA 02115 USA Division of Gynecologic Oncology Department of Obstetrics and GynecologyMassachusetts General HospitalBostonMA 02114USA
Epithelial ovarian cancer(EOC)is treated in the first-line setting with combined platinum and taxane chemotherapy,often followed by a maintenance poly(ADP-ribose)polymerase inhibitor(PARPi).Responses to first-line tre... 详细信息
来源: 维普期刊数据库 维普期刊数据库 评论